Clinical trial
A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind…
NCT00381602 · QLT Inc., Industry · Terminated
Key facts
| NCT number | NCT00381602 |
|---|---|
| Title | A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis |
| Lead sponsor | QLT Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | End Stage Renal Disease |
| Intervention type | Drug, Other |
| Interventions | GHRP-1/AG 70 mg depot in ESRD, Placebo |
| Enrollment | 3 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Sep 28, 2006 |
| Last update posted | Apr 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: